Related Experiment Video

Updated: Aug 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance

Roman Kulikov1, Karen A Boehme, Christine Blattner

  • 1Institut für Genetik, Forschungszentrum Karlsruhe, Germany.

Molecular and Cellular Biology
|August 2, 2005
PubMed

Insights

Glycogen synthase kinase 3 (GSK-3) phosphorylates Mdm2, marking it for p53 degradation. Inhibiting GSK-3 stabilizes p53, a key tumor suppressor, especially after radiation exposure.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Mdm2 oncoprotein regulates p53 tumor suppressor protein levels.
  • Mdm2 phosphorylation is crucial for p53 degradation.
  • Glycogen synthase kinase 3 (GSK-3) is a key regulator of cellular processes.

Purpose of the Study:

  • To investigate the role of GSK-3 in Mdm2 phosphorylation.
  • To determine the effect of GSK-3 inhibition on p53 stability.
  • To explore the link between GSK-3 activity and p53 regulation in response to DNA damage.

Main Methods:

  • In vitro and in vivo phosphorylation assays using GSK-3 and Mdm2.
  • Inhibition of GSK-3 using specific inhibitors.
  • Analysis of p53 and Mdm2 protein levels, localization, and interactions.
  • Expression of GSK-3 mutants to assess functional impact.
  • Exposure to ionizing radiation to induce DNA damage.

Main Results:

  • GSK-3 directly phosphorylates Mdm2 in its central domain.
  • GSK-3 inhibition leads to p53 stabilization, independent of Mdm2 interaction or localization.
  • Ionizing radiation induces GSK-3 phosphorylation at serine 9, preceding p53 accumulation.
  • A GSK-3 mutant (S9A) reduces p53 and p21(WAF-1) induction after radiation.

Conclusions:

  • GSK-3 activity is essential for Mdm2-mediated p53 degradation.
  • Inhibition of GSK-3 contributes to Mdm2 hypophosphorylation and subsequent p53 stabilization.
  • GSK-3 is a critical mediator in the p53 response pathway to DNA damage.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...